✨ Your Portfolio is fetched and updated from zerodha.

Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (232 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
36.84
4,02,584
83.13
1,82,147
22.94
1,20,941
59.30
1,13,325
18.77
1,06,138
22.14
1,00,176
49.47
98,492
27.38
89,863
53.17
75,200
19.29
67,242
26.90
58,259
60.23
55,871
47.70
49,950
48.61
49,254
114
40,884
138
37,010
47.23
34,840
34.59
31,841
44.01
30,741
-
27,595
297
27,143
34.06
26,142
38.85
25,623
35.36
24,094
-
23,051
67.90
22,988
194
22,546
63.12
22,208
33.34
19,453
22.73
19,079
49.47
18,385
8.76
16,511
96.72
16,455
59.11
15,376
28.11
15,076
47.63
14,536
34.03
14,064
33.68
13,696
154
12,872
25.54
12,401
72.85
12,261
23.73
11,902
30.64
11,660
70.72
10,630
38.57
9,690
26.79
9,060
56.65
8,991
109
8,576
29.86
8,133
2.23
8,011
29.87
7,968
31.18
5,860
-
5,388
37.79
4,847
212
4,641
26.25
4,414
47.01
4,268
22.59
4,140
30.03
4,130
-
3,982
77.72
3,790
36.81
3,669
27.60
3,619
50.39
3,510
28.65
3,381
-
3,337
-
3,116
10.01
3,110
-
2,956
27.81
2,811
45.73
2,678
-
2,591
73.32
2,330
32.22
2,151
30.51
2,109
40.79
2,074
23.83
1,946
31.20
1,903
36.45
1,802
41.81
1,773
19.41
1,636
55.71
1,531
27.57
1,526
34.56
1,484
30.16
1,202
38.75
1,156
13.58
1,118
22.50
1,066
305
1,027
12.72
978
29.76
909
23.10
890
-
802
44.42
778
32.49
750
34.80
735
-
727
27.04
722
44.96
717
72.26
692
2.82
678
20.20
668
35.82
650
13.56
615
19.17
615
77.18
549
44.38
540
30.09
512
29.71
511
22.55
500
-
498
22.66
454
-
433
-
422
50.87
408
69.58
391
18.32
381
17.84
359
35.79
344
-
341
33.39
337
27.63
325
29.71
292
21.50
287
335
284
17.51
282
56.76
280
32.74
265
367
227
11.27
220
8.87
214
51.52
214
21.71
208
439
202
-
201
49.55
199
13.99
193
25.22
190
-
188
660
171
88.29
162
22.39
162
11.72
159
19.79
159
40.24
153
16.37
152
12.15
151
183
150
39.60
141
17.24
139
12.46
134
19.79
133
34.70
130
13.09
126
24.32
126
30.20
125
10.37
119
19.19
118
645
112
15.44
110
-
102
32.47
102
34.28
100
11.81
96
0.32
91
17.93
89
11.59
87
11.50
78
135
75
10.13
74
15.42
68
-
62
13.91
59
-
58
13.73
57
153
51
-
50
15.18
50
49.20
49
6.70
49
31.17
48
23.52
48
41.43
48
20.00
46
110
45
51.02
44
13.02
43
95.61
42
-
41
102
40
-
39
-
38
-
38
161
36
35.73
36
13.45
35
61.92
33
44.25
33
-
31
12.57
26
128
26
28.88
25
-
24
347
23
-
18
59.99
18
-
18
50.16
17
-
17
49.61
16
33.67
16
63.29
15
14.08
15
-
14
-
13
-
12
20.55
12
21.61
11
-
11
-
11
25.39
10
-
10
41.28
10
94.39
10
106
6
-
6
-
6
82.59
6
-
5
-
5
22.73
4
-
1
Showing 5 232 of 232 Show More
Market Share

    Select a Metric
    • Fermentation Based API Products - Market Share (%)
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Vaccines - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Benzimidazole (%)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Timeline
        Watchlist
        Portfolio
        Alerts
        Research
        Stock Screener
        Market
        Raw Material